Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors

被引:56
作者
Grandt, D
Schimiczek, M
Rascher, W
Feth, F
Shively, J
Lee, TD
Davis, MT
Reeve, JR
Michel, MC
机构
[1] UNIV GIESSEN, DEPT PEDIAT, GIESSEN, GERMANY
[2] CITY HOPE NATL MED CTR, BECKMAN RES INST, DIV IMMUNOL, DUARTE, CA 91010 USA
[3] UNIV CALIF LOS ANGELES, CTR DIGEST DIS, CURE, LOS ANGELES, CA 90073 USA
[4] VET ADM WADSWORTH MED CTR, LOS ANGELES, CA 90073 USA
关键词
neuropeptide Y; neurotransmitter; receptor; molecular heterogeneity; pig; brain; HPLC; radioimmunoassay;
D O I
10.1016/S0167-0115(96)00104-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuropeptide Y (NPY 1-36) binds to Y1 and Y2 receptors with similar affinity. No endogenous molecular form of NPY with selectivity for Y1 or Y2 receptors has been described so far. We report the presence of an endogenous fragment of NPY in porcine brain, NPY 3-36, which lacks the amino-terminal dipeptide Tyr-Pro of NPY 1-36. NPY 3-36 accounts for 35% of NPY-like immunoreactivity in porcine brain. We have compared binding of NPY 3-36 and NPY 1-36 in model systems of Y1-like (SK-N-MC cells) and Y2-like receptors (CHP234 cells). NPY 3-36 and NPY 1-36 had similarly high affinity for Y2-like receptors on CHP234 cells, but NPY 3-36 had a 1000-fold lower affinity than NPY 1-36 for Y1-like receptors on SK-N-MC cells. Thus amino-terminal cleavage of NPY 1-36 generating NPY 3-36 converts an unselective Y1/Y2 receptor ligand into a highly Y2 selective ligand. This may be a means of fine tuning NPY biological actions.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 23 条
[1]   KINETICS OF DIPEPTIDYL PEPTIDASE-IV PROTEOLYSIS OF GROWTH HORMONE-RELEASING FACTOR AND ANALOGS [J].
BONGERS, J ;
LAMBROS, T ;
AHMAD, M ;
HEIMER, EP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (02) :147-153
[2]   ON THE INFLUENCE OF HYDROPHOBICITY IN THE SIMS SPECTRA OF AMINO-ACIDS IN GLYCEROL MATRIX [J].
DEPAUW, E ;
PELZER, G ;
DUNG, DV ;
MARIEN, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 123 (01) :27-32
[3]   A NEW MOLECULAR-FORM OF PYY - STRUCTURAL CHARACTERIZATION OF HUMAN PYY(3-36) AND PYY(1-36) [J].
EBERLEIN, GA ;
EYSSELEIN, VE ;
SCHAEFFER, M ;
LAYER, P ;
GRANDT, D ;
GOEBELL, H ;
NIEBEL, W ;
DAVIS, M ;
LEE, TD ;
SHIVELY, JE ;
REEVE, JR .
PEPTIDES, 1989, 10 (04) :797-803
[4]   STRUCTURAL CHARACTERIZATION OF CANINE PYY [J].
EYSSELEIN, VE ;
EBERLEIN, GA ;
GRANDT, D ;
SCHAEFFER, M ;
ZEHRES, B ;
BEHN, U ;
SCHAEFER, D ;
GOEBELL, H ;
DAVIS, M ;
LEE, TD ;
SHIVELY, JE ;
MEYER, HE ;
REEVE, JR .
PEPTIDES, 1990, 11 (01) :111-116
[5]   NEUROPEPTIDE-Y (NPY) RECEPTORS IN HEL CELLS - COMPARISON OF BINDING AND FUNCTIONAL PARAMETERS FOR FULL AND PARTIAL AGONISTS AND A NONPEPTIDE ANTAGONIST [J].
FETH, F ;
RASCHER, W ;
MICHEL, MC .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (01) :71-76
[6]  
FETH F, 1991, N-S ARCH PHARMACOL, V344, P1
[7]   2 MOLECULAR-FORMS OF PEPTIDE YY (PYY) ARE ABUNDANT IN HUMAN BLOOD - CHARACTERIZATION OF A RADIOIMMUNOASSAY RECOGNIZING PYY-1-36 AND PYY-3-36 [J].
GRANDT, D ;
SCHIMICZEK, M ;
BEGLINGER, C ;
LAYER, P ;
GOEBELL, H ;
EYSSELEIN, VE ;
REEVE, JR .
REGULATORY PEPTIDES, 1994, 51 (02) :151-159
[8]   NOVEL GENERATION OF HORMONE RECEPTOR SPECIFICITY BY AMINO TERMINAL PROCESSING OF PEPTIDE-YY [J].
GRANDT, D ;
TEYSSEN, S ;
SCHIMICZEK, M ;
REEVE, JR ;
FETH, F ;
RASCHER, W ;
HIRCHE, H ;
SINGER, MV ;
LAYER, P ;
GOEBELL, H ;
HO, FJ ;
EYSSELEIN, VE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (03) :1299-1306
[9]  
HAWKE D, 1982, ANAL BIOCHEM, V120, P302, DOI 10.1016/0003-2697(82)90351-7
[10]   PREPARATION OF IODINE-131 LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC ACTIVITY [J].
HUNTER, WM ;
GREENWOOD, FC .
NATURE, 1962, 194 (4827) :495-&